Context Therapeutics Inc. (CNTX)
(Real Time Quote from BATS)
$0.70 USD
+0.02 (2.94%)
Updated Aug 5, 2025 03:02 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Context Therapeutics Inc. has a market cap of $61.00M, which represents its share price of $0.68 multiplied by its outstanding shares number of 89.70M. As a small-cap company, CNTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CNTX 0.70 +0.02(2.94%)
Will CNTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CNTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNTX
Bet on These 5 Top-Ranked Stocks With Rising P/E
Zacks.com featured highlights include Context Therapeutics, Blue Bird, Dycom Industries and Leidos
CNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bet on 4 Top-Ranked Stocks With Rising P/E for Solid Gains
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?
Other News for CNTX
Rare Stock Picks In June 2025 - From 26 Discerning Analysts
Piper Sandler Remains a Buy on Context Therapeutics (CNTX)
Piper Sandler Adjusts Price Target for Context Therapeutics (CNTX) | CNTX Stock News
Context Therapeutics (CNTX) Price Target Reduced by Piper Sandler | CNTX Stock News
Context Therapeutics price target lowered to $4 from $4.50 at Piper Sandler